H David Humes Selected Research

Hemofiltration

1/2012	Bioartificial Renal Epithelial Cell System (BRECS): A Compact, Cryopreservable Extracorporeal Renal Replacement Device.
1/2008	The bioartificial kidney and bioengineered membranes in acute kidney injury.
1/2005	Stem cells: the next therapeutic frontier.
4/2004	Advances in cell therapy for renal failure.
1/2004	Renal cell therapy in the treatment of patients with acute and chronic renal failure.
2/2003	Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals.
1/2003	Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure.
5/2002	Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells.
5/2002	The bioartificial kidney in the treatment of acute renal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H David Humes Research Topics

Disease

17	Acute Kidney Injury (Acute Renal Failure) 05/2022 - 05/2002
12	Renal Insufficiency (Renal Failure) 05/2022 - 01/2002
11	Chronic Kidney Failure (Chronic Renal Failure) 11/2017 - 05/2002
5	Sepsis (Septicemia) 05/2022 - 01/2002
5	Septic Shock (Toxic Shock Syndrome) 05/2022 - 01/2002
4	Critical Illness (Critically Ill) 03/2021 - 05/2008
3	COVID-19 05/2022 - 11/2020
2	Multiple Organ Failure (MODS) 05/2022 - 02/2013
2	Cytokine Release Syndrome 01/2021 - 11/2020
2	Hyperkalemia 01/2017 - 01/2004
2	Infections 09/2016 - 10/2003
2	Chronic Renal Insufficiency 03/2014 - 01/2012
1	Lactic Acidosis 05/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Inflammation (Inflammations) 11/2020
1	Epistaxis (Nosebleed) 01/2017
1	Multiple Myeloma 01/2017
1	Tumor Lysis Syndrome 01/2017
1	Hyperuricemia 01/2017
1	Hyperphosphatemia 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2016
1	Type 2 Diabetes Mellitus (MODY) 09/2016
1	Insulin Resistance 01/2016
1	Wounds and Injuries (Trauma) 02/2013
1	Chronic Disease (Chronic Diseases) 02/2013
1	Uremia 01/2004
1	Body Weight (Weight, Body) 10/2003
1	Shock 05/2002

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 05/2022 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 11/2020
2	Citric Acid (Citrate)FDA LinkGeneric 05/2022 - 04/2011
2	InterleukinsIBA 05/2022 - 11/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2020
2	C-Reactive ProteinIBA 01/2021 - 09/2016
2	Biological ProductsIBA 11/2017 - 08/2006
2	EndotoxinsIBA 05/2002 - 01/2002
1	Interleukin-10 (Interleukin 10)IBA 05/2022
1	Interleukin-15 (Interleukin 15)IBA 05/2022
1	Ferritins (Ferritin)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2017
1	Dabigatran FDA Link 01/2017
1	elotuzumabIBA 01/2017
1	Aligeron (AS 2)IBA 09/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	CalciumIBA 04/2011
1	salicylhydroxamic acid (SHAM)IBA 10/2003
1	CreatinineIBA 02/2003
1	NitrogenIBA 02/2003
1	Urea (Carbamide)FDA LinkGeneric 02/2003
1	Inflammation MediatorsIBA 01/2002

Therapy/Procedure

18	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2017 - 05/2002
13	Therapeutics 05/2022 - 01/2002
10	Renal Dialysis (Hemodialysis) 05/2022 - 05/2002
9	Hemofiltration 01/2012 - 05/2002
6	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2022 - 01/2002
5	Continuous Renal Replacement Therapy 05/2022 - 01/2002
4	Immunomodulation 05/2022 - 11/2020
2	Hemodiafiltration 05/2022 - 09/2012
1	Artificial Respiration (Mechanical Ventilation) 05/2022
1	Extracorporeal Membrane Oxygenation 11/2020
1	Peritoneal Dialysis 11/2017
1	Aftercare (After-Treatment) 01/2017
1	Critical Care (Surgical Intensive Care) 12/2009
1	Kidney Transplantation 05/2006
1	Transplantation 09/2005